Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dimension in defining tumor response.

Literature DB >> 9508213

Dimension in defining tumor response.

R Chappell, S S Miranpuri, M P Mehta.

Abstract

Entities: Disease

Mesh：

Year: 1998 PMID： 9508213 DOI： 10.1200/JCO.1998.16.3.1234

Source DB: PubMed Journal: J Clin Oncol ISSN： 0732-183X Impact factor: 44.544

Keyword Cloud
Cited

× No keyword cloud information.

7 in total

1. Volumetric response quantified using T1 subtraction predicts long-term survival benefit from cabozantinib monotherapy in recurrent glioblastoma.

Authors: Benjamin M Ellingson; Dana T Aftab; Gisela M Schwab; Colin Hessel; Robert J Harris; Davis C Woodworth; Kevin Leu; Ararat Chakhoyan; Catalina Raymond; Jan Drappatz; John de Groot; Michael D Prados; David A Reardon; David Schiff; Marc Chamberlain; Tom Mikkelsen; Annick Desjardins; Jaymes Holland; Jerry Ping; Ron Weitzman; Patrick Y Wen; Timothy F Cloughesy
Journal: Neuro Oncol Date: 2018-09-03 Impact factor: 12.300

2. Volumetric measurements are preferred in the evaluation of mutant IDH inhibition in non-enhancing diffuse gliomas: Evidence from a phase I trial of ivosidenib.

Authors: Benjamin M Ellingson; Grace Hyun J Kim; Matt Brown; Jihey Lee; Noriko Salamon; Lori Steelman; Islam Hassan; Shuchi S Pandya; Saewon Chun; Michael Linetsky; Bryan Yoo; Patrick Y Wen; Ingo K Mellinghoff; Jonathan Goldin; Timothy F Cloughesy
Journal: Neuro Oncol Date: 2022-05-04 Impact factor: 13.029

3. Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placebo.

Authors: Benjamin M Ellingson; Lauren E Abrey; Josep Garcia; Olivier Chinot; Wolfgang Wick; Frank Saran; Ryo Nishikawa; Roger Henriksson; Warren P Mason; Robert J Harris; Kevin Leu; Davis C Woodworth; Arnav Mehta; Catalina Raymond; Ararat Chakhoyan; Whitney B Pope; Timothy F Cloughesy
Journal: Neuro Oncol Date: 2018-10-09 Impact factor: 12.300

4. Comparison of Measurement Techniques and Response Criteria for MR Imaging Follow-up in Adult Primary Central Nervous System Lymphoma.

Authors: K Massicotte-Tisluck; D Vanderweyen; J-F Vendrell; D Fortin; G Gahide
Journal: AJNR Am J Neuroradiol Date: 2021-04-29 Impact factor: 4.966

Dimension in defining tumor response.

1. Volumetric response quantified using T1 subtraction predicts long-term survival benefit from cabozantinib monotherapy in recurrent glioblastoma.

2. Volumetric measurements are preferred in the evaluation of mutant IDH inhibition in non-enhancing diffuse gliomas: Evidence from a phase I trial of ivosidenib.

3. Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placebo.

4. Comparison of Measurement Techniques and Response Criteria for MR Imaging Follow-up in Adult Primary Central Nervous System Lymphoma.

5. Local tumour response to neoadjuvant therapy with 2-aminoethyl dihydrogen phosphate in dogs with soft tissue sarcoma.

Review 6. Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials.

7. Longitudinal Patterns in Clinical and Imaging Measurements Predict Residual Survival in Glioblastoma Patients.